A pilot clinical trial in the U.S. is enrolling people with relapsing-remitting multiple sclerosis (RRMS) to test Setpoint Medical’s implantable nerve stimulation device, which is designed to reduce inflammation and promote myelin repair. The trial (NCT06796504) is enrolling up to 60 people, ages 22-50, and will evaluate the safety and potential remyelinating effects of the […]
The post Pilot trial tests nerve stimulator to repair myelin damage in RRMS appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com